Carregant...
Miniatura

Tipus de document

Article

Versió

Versió publicada

Data de publicació

Llicència de publicació

cc by (c) Soler Botija, Carolina et al, 2022
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/184278

Mechanisms governing the therapeutic effect of mesenchymal stromal cell-derived extracellular vesicles: A scoping review of preclinical evidence

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

Compelling evidence supports the therapeutic benefit of extracellular vesicles (EVs). EVs are nanostructures with a lipid bilayer membrane that are secreted by multiple cells, including mesenchymal stromal cells (MSCs), as means of cellular communication. MSC-EVs, resembling their MSC origin, carry protected immunomodulatory and pro-regenerative cargoes to targeted neighboring or distant cells and tissues. Though treatments focused on MSC-EVs have emerged as greatly versatile approaches to modulate multiple inflammatory-related conditions, crucial concerns, including the possibility of increasing therapeutic outcomes by pre-conditioning parental MSCs or engineering derived EVs and clarification of the most relevant mechanisms of action, remain. Here, we summarize the large amount of preclinical research surrounding the modulation of beneficial effects by MSC-EVs.

Matèries (anglès)

Citació

Citació

SOLER BOTIJA, Carolina, MONGUIÓ TORTAJADA, Marta, MUNIZAGA LARROUDÉ, Micaela, GÁLVEZ MONTÓN, Carolina, BAYÉS GENÍS, Antoni, ROURA, Santiago. Mechanisms governing the therapeutic effect of mesenchymal stromal cell-derived extracellular vesicles: A scoping review of preclinical evidence. _Biomedicine & Pharmacotherapy_. 2022. Vol.  vol 147. [consulta: 25 de febrer de 2026]. ISSN: 0753-3322. [Disponible a: https://hdl.handle.net/2445/184278]

Exportar metadades

JSON - METS

Compartir registre